Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y [electronic resource]
Producer: 20210308Description: e015865 p. digitalISSN:- 2047-9980
- Aged
- Aspirin -- adverse effects
- Dual Anti-Platelet Therapy -- adverse effects
- Female
- Florida
- Hemorrhage -- chemically induced
- Humans
- Lactones -- adverse effects
- Male
- Middle Aged
- Myocardial Infarction -- blood
- Platelet Aggregation -- drug effects
- Platelet Aggregation Inhibitors -- adverse effects
- Prasugrel Hydrochloride -- adverse effects
- Prospective Studies
- Purinergic P2Y Receptor Antagonists -- adverse effects
- Pyridines -- adverse effects
- Thrombosis -- blood
- Ticagrelor -- adverse effects
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.